SERMONIX
Live / Registered — Registered (as of 23 Jan 2024)
What this means for you
Registered since 23 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88681484
- Registration number
- 7287507
- Mark type
- Stylized text
- Filed
- 05 Nov 2019
- Published for opposition
- 15 Sept 2020
- Registered
- 23 Jan 2024
- Attorney of record
- Karen A. Webb, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparation for post-menopausal women's health, namely, to prevent and treat breast cancer, osteoporosis and vulvovaginal atrophy
Owner
- Sermonix Pharmaceuticals, Inc., Columbus, OH, US
- Sermonix Pharmaceuticals, Inc., Columbus, OH, US
- Sermonix Pharmaceuticals, Inc., Columbus, OH, US
Prosecution history
- 23 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 19 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Nov 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Aug 2023 — NON-FINAL ACTION E-MAILED
- 16 Aug 2023 — SU - NON-FINAL ACTION - WRITTEN
- 19 Jul 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Jul 2023 — USE AMENDMENT FILED
- 17 Jul 2023 — TEAS STATEMENT OF USE RECEIVED
- 09 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 May 2023 — SOU EXTENSION 5 GRANTED